Cobalt International Energy, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of Cobalt International Energy, Inc. ("CIE"). Specifically, on August 5, 2014, the Company disclosed that it received an SEC Wells Notice in connection with the company's Angolan operations.

For information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

DreamWorks Animation SKG, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the Central District of California alleging that DreamWorks Animation SKG, Inc. ("DWA") violated federal securities laws between October 29, 2013 and July 29, 2014. On July 29, 2014, the Company disclosed that the SEC is conducting an investigation related to the Company's prior write-down of film inventory for Turbo.

For information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

Galectin Therapeutics, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the District of Nevada alleging that Galectin Therapeutics, Inc. ("GALT") violated federal securities laws between January 6, 2014 and July 28, 2014. Specifically, the Complaint alleges that Galectin was paying for misleading promotional campaigns to entice investors to buy its stock.

For information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

Impax Laboratories, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of Impax Laboratories, Inc. ("IPXL"). Specifically, on July 29, 2014, the Company disclosed that the Food and Drug Administration uncovered several issues at the Company's Taiwan facility where IPXL manufactures Rytary, an experimental Parkinson's disease drug.

For information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

Peoples Federal Bancshares, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Peoples Federal Bancshares, Inc. ("PEOP") to Independent Bank Corp. in a cash and stock transaction valued at approximately $21.00 per share or $130.6 million.

Lifshitz & Miller's investigation is focused on whether the PEOP directors are acting in shareholders best interest.

For more information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

Siuslaw Financial Group, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Siuslaw Financial Group, Inc. ("SFGP") to Banner Corporation in a cash and stock transaction valued at approximately $14.03 per share or $57.5 million.

For more information about our investigation, please contact Email Contact by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: Email Contact.

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: Email Contact

SOURCE Lifshitz & Miller Law Firm